Literature DB >> 10074484

Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis.

D Tricarico1, S Servidei, P Tonali, K Jurkat-Rott, D C Camerino.   

Abstract

The adenosine triphosphate (ATP)-sensitive K+ (KATP) channel is the most abundant K+ channel active in the skeletal muscle fibers of humans and animals. In the present work, we demonstrate the involvement of the muscular KATP channel in a skeletal muscle disorder known as hypokalemic periodic paralysis (HOPP), which is caused by mutations of the dihydropyridine receptor of the Ca2+ channel. Muscle biopsies excised from three patients with HOPP carrying the R528H mutation of the dihydropyridine receptor showed a reduced sarcolemma KATP current that was not stimulated by magnesium adenosine diphosphate (MgADP; 50-100 microM) and was partially restored by cromakalim. In contrast, large KATP currents stimulated by MgADP were recorded in the healthy subjects. At channel level, an abnormal KATP channel showing several subconductance states was detected in the patients with HOPP. None of these were surveyed in the healthy subjects. Transitions of the KATP channel between subconductance states were also observed after in vitro incubation of the rat muscle with low-K+ solution. The lack of the sarcolemma KATP current observed in these patients explains the symptoms of the disease, i.e., hypokalemia, depolarization of the fibers, and possibly the paralysis following insulin administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074484      PMCID: PMC408119          DOI: 10.1172/JCI4552

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Molecular pathophysiology of voltage-gated ion channels.

Authors:  F Lehmann-Horn; R Rüdel
Journal:  Rev Physiol Biochem Pharmacol       Date:  1996       Impact factor: 5.545

2.  Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition.

Authors:  M Vivaudou; C Forestier
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

3.  ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties.

Authors:  D Tricarico; D C Camerino
Journal:  Mol Pharmacol       Date:  1994-10       Impact factor: 4.436

4.  Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis?

Authors:  T P Links; A J Smit; H J Oosterhuis; W D Reitsma
Journal:  Clin Sci (Lond)       Date:  1993-09       Impact factor: 6.124

5.  Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.

Authors:  L Aguilar-Bryan; C G Nichols; S W Wechsler; J P Clement; A E Boyd; G González; H Herrera-Sosa; K Nguy; J Bryan; D A Nelson
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

Review 6.  Ion-channel defects and aberrant excitability in myotonia and periodic paralysis.

Authors:  S C Cannon
Journal:  Trends Neurosci       Date:  1996-01       Impact factor: 13.837

7.  Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle.

Authors:  H Sakura; C Ammälä; P A Smith; F M Gribble; F M Ashcroft
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

8.  A calcium channel mutation causing hypokalemic periodic paralysis.

Authors:  K Jurkat-Rott; F Lehmann-Horn; A Elbaz; R Heine; R G Gregg; K Hogan; P A Powers; P Lapie; J E Vale-Santos; J Weissenbach
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

9.  Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells.

Authors:  P Lapie; C Goudet; J Nargeot; B Fontaine; P Lory
Journal:  FEBS Lett       Date:  1996-03-18       Impact factor: 4.124

10.  Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.

Authors:  L J Ptácek; R Tawil; R C Griggs; A G Engel; R B Layzer; H Kwieciński; P G McManis; L Santiago; M Moore; G Fouad
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  30 in total

Review 1.  Periodic paralysis: understanding channelopathies.

Authors:  Frank Lehmann-Horn; Karin Jurkat-Rott; Reinhardt Rüdel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 2.  Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis.

Authors:  R L Ruff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 3.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

4.  The KATP channel is a molecular sensor of atrophy in skeletal muscle.

Authors:  Domenico Tricarico; Antonietta Mele; Giulia Maria Camerino; Roberto Bottinelli; Lorenza Brocca; Antonio Frigeri; Maria Svelto; Alfred L George; Diana Conte Camerino
Journal:  J Physiol       Date:  2010-01-11       Impact factor: 5.182

Review 5.  Voltage-sensor mutations in channelopathies of skeletal muscle.

Authors:  Stephen C Cannon
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

6.  Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+) -depleted rats.

Authors:  D Tricarico; S Lovaglio; A Mele; G Rotondo; E Mancinelli; G Meola; D C Camerino
Journal:  Br J Pharmacol       Date:  2008-03-17       Impact factor: 8.739

Review 7.  Sodium channelopathies of skeletal muscle result from gain or loss of function.

Authors:  Karin Jurkat-Rott; Boris Holzherr; Michael Fauler; Frank Lehmann-Horn
Journal:  Pflugers Arch       Date:  2010-03-17       Impact factor: 3.657

8.  Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel.

Authors:  Domenico Tricarico; Mariagrazia Barbieri; Laghezza Antonio; Paolo Tortorella; Fulvio Loiodice; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

Review 10.  Human K(ATP) channelopathies: diseases of metabolic homeostasis.

Authors:  Timothy M Olson; Andre Terzic
Journal:  Pflugers Arch       Date:  2009-12-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.